Tissue Repair Profit Margin

Tissue Repair posts a profit margin of -300.67% as of June 2026. That compares with -463.37% in the prior-year period — up 35.1% year over year. That is below the Healthcare sector average of 9.48%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Tissue Repair's profit margin was -463.37%. The latest reading is -300.67% — a 35.1% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.48% is typical. Tissue Repair's -300.67% is lower that level. That is roughly 3271.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Tissue Repair's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -300.67% as of June 2026; use YoY and peer views to separate noise from signal.

Context for TRP.AX's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.48%), and (3) consistency with growth and profitability. This page covers the first two; Tissue Repair's other metric pages and overview cover the third.